von Tobias Borgers | Juli 29, 2019 | Glaxo
Issued: London, UK ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the submission of a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for...
von Tobias Borgers | Juli 29, 2019 | GEA
Im Geschäftsjahr 2018 und auf Basis konstanter Wechselkurse: stieg der Umsatz um rund 7,9 Prozent (zuletzt prognostiziert: etwa plus 7,5 Prozent)
betrug die operative EBITDA Marge rund 10,5 Prozent (zuletzt prognostiziert: 11,1 Prozent)
lag die operative...
von Tobias Borgers | Juli 29, 2019 | Continuous Manufacturing
The research study on Global Bio Pharma Logistics Market organizes the overall perspective of the Bio Pharma Logistics industry. This incorporates upcoming flow of the Bio Pharma Logistics market together with an extensive analysis of recent industry statistics. It...
von Tobias Borgers | Juli 29, 2019 | Tablet Coating
Need of calcium sulfate in building materials and in dental industry as casts or dental impression forming tool will enhance the global calcium sulfate market in upcoming year. Moreover, application of calcium sulfate in construction sector in paints & coatings,...
von Tobias Borgers | Juli 29, 2019 | Allgemein
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced that Part 1a of the Phase 3 CheckMate -227 trial evaluating Opdivo ® (nivolumab) plus low-dose Yervoy ® (ipilimumab) met the co-primary endpoint of overall survival...
